Piramal Enterprises Ltd.

NSE: PEL BSE: 500302 SECTOR: Pharmaceuticals & Drugs

2503.55
-131.15 (-4.98%)
NSE: 20 Sep 04:12 PM

Price Summary

Today's High

₹ 2632

Today's Low

₹ 2492.55

52 Week High

₹ 2858

52 Week Low

₹ 1178.55

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.

Company Essentials

Market Cap

59750.63 Cr.

Enterprise Value

65456.42 Cr.

No. of Shares

23.87 Cr.

P/E

847.66

P/B

2.37

Face Value

₹ 2

Div. Yield

1.32%

Book Value (TTM)

₹  1055.32

CASH

966.11 Cr.

DEBT

6671.9 Cr.

Promoter Holding

43.52%

EPS (TTM)

₹  2.95

Sales Growth

-31.25%

ROE

0.17 %

ROCE

3.77 %

Profit Growth

-72.45 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Brands

Lacto Calamine Tetmosol Neko Caladryl Polycrol Digeplex i-pill i-know i-can jungle mgic kids little's baby care Saridon Sloan's Quikkool Naturoplax Lactobacil Plus Throatsil Stop AllerG Untox Supradyn Ferradol

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Ratios

Sales Growth

1 Year-31.25%
3 Year-4.1%
5 Year-3.04%

Profit Growth

1 Year-72.45%
3 Year-57.46%
5 Year-47.45%

ROE%

1 Year0.17%
3 Year-1.13%
5 Year1.04%

ROCE %

1 Year3.77%
3 Year4.03%
5 Year5.21%

Debt/Equity

0.2878

Price to Cash Flow

26.48

Interest Cover Ratio

1.11179206003163

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2021 43.52 0
Mar 2021 46.06 0
Dec 2020 46.06 0
Sep 2020 46.06 0
Jun 2020 46.06 0
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 3903.62 Cr.
  • The Company has been maintaining an effective average operating margins of 40.4779226582108% in the last 5 years.
  • The company has an efficient Cash Conversion Cycle of -96.417956146973 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.73092933484256.

 Limitations

  • The company has shown a poor profit growth of -57.464675091048% for the Past 3 years.
  • The company has shown a poor revenue growth of -4.09940944050164% for the Past 3 years.
  • Company has a poor ROE of -1.13011152426163% over the past 3 years.
  • Company has a poor ROCE of 4.03309166654014% over the past 3 years
  • The company is trading at a high PE of 847.66.
  • The company is trading at a high EV/EBITDA of 44.496.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
Net Sales 354.51 1026.45 563.08 493.59 512.78
Total Expenditure 95.58 576.41 222.9 199.09 301.34
Operating Profit 258.93 450.04 340.18 294.5 211.44
Other Income 29.57 92.71 22.85 23.04 35.98
Interest 287.92 345.95 254.02 180.88 183.46
Depreciation 10.05 38.14 8.7 7.44 4.97
Exceptional Items 0 -37.42 -258.35 0 0
Profit Before Tax -9.47 121.24 -158.04 129.22 58.99
Tax -1.57 17.93 6.62 50.51 5.86
Profit After Tax -7.9 103.31 -164.66 78.71 53.13
Adjusted EPS (Rs) -0.35 4.58 -7.3 3.49 2.23

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Net Sales 3766.21 3288.63 3670.85 4219.18 2900.54
Total Expenditure 2153.98 2076.5 2013.58 2628.71 1723.64
Operating Profit 1612.23 1212.13 1657.27 1590.47 1176.9
Other Income 580.53 642.45 461.57 701.37 339.95
Interest 1178.34 989.55 1497.27 1710.06 1068.77
Depreciation 94.49 111.58 131.22 41.94 32.82
Exceptional Items 0 0 -1287.96 0 -295.78
Profit Before Tax 919.93 753.45 -797.61 539.84 119.48
Tax 143.15 234.98 70.4 394.99 79.58
Net Profit 776.78 518.47 -868.01 144.85 39.9
Adjusted EPS (Rs.) 43.69 28.08 -45.94 6.42 1.77

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Equity and Liabilities
Share Capital 34.51 36.05 36.89 45.11 45.11
Total Reserves 14388.09 21300.8 19455.04 22582.87 23138.63
Borrowings 2739.52 4011.56 4619.83 2389.78 3386.21
Other N/C liabilities 4150.47 4487.13 4599.97 4626.66 4527.36
Current liabilities 8427.57 11426.64 13786.19 9635.95 4402.57
Total Liabilities 29740.16 41262.18 42497.92 39280.37 35499.88
Assets
Net Block 1074.8 1807.19 1823.9 1789.26 91.2
Capital WIP 575.21 77.18 45.91 62.8 1.31
Intangible WIP 26.65 34.53 52.04 56.63 0
Investments 15607.64 20867.45 22044.81 18452.21 20298.38
Loans & Advances 8392.15 13440.31 15556.69 15797.95 11548.55
Other N/C Assets 19.06 26.72 5.85 0.9 35.93
Current Assets 4044.65 5008.8 2968.72 3120.62 3524.51
Total Assets 29740.16 41262.18 42497.92 39280.37 35499.88
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Profit from operations 919.93 753.45 490.35 539.83 415.26
Adjustment -56.05 -41.23 149.73 346.39 -107.9
Changes in Assets & Liabilities -7022.94 -5446.85 6285.52 310.83 2028.25
Tax Paid -188.62 -175.84 -178.73 -63.54 -78.94
Operating Cash Flow -6347.68 -4910.47 6746.87 1133.51 2256.67
Investing Cash Flow -2424.41 -4403.39 -9328.91 1886.88 2678.94
Financing Cash Flow 8887.2 9690.02 2068.67 -4543.56 -2465.68
Net Cash Flow 115.11 376.16 -513.37 -1523.17 2469.93

Corporate Actions

Investors Details

PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
Promoters 46.06 46.06 46.06 46.06 43.52
aasan info solutions (ind... 0.89 0.89 0.89 0.89 0.84
master dev piramal deyoun... 0.02 0.02 0.02 0.02 0.02
mr. ajay g. piramal 0.05 0.05 0.05 0.05 0.05
mr. anand piramal 0.09 0.09 0.09 0.09 0.08
mr. peter deyoung 0.05 0.05 0.05 0.05 0.05
ms. anya piramal deyoung 0.02 0.02 0.02 0.02 0.02
ms. nandini piramal 0.02 0.02 0.02 0.02 0.02
piramal welfare trust (fo... 1.1 1.1 1.1 1.1 1.03
prl realtors llp 3.98 3.98 3.98 3.98 3.76
the ajay g. piramal found... 0.44 0.44 0.44 0.44 0.41
anand piramal trust 0.06 0.06 0.06 0.06 0.06
nandini piramal trust 0.05 0.05 0.05 0.05 0.05
the sri krishna trust thr... 34.97 34.97 34.97 34.97 33.05
v3 designs llp 4.3 4.3 4.3 4.3 4.06
PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
Public 14.52 14.81 14.8 14.33 13.4
iepf 0.31 0.33 0.33 0.33 0.31
indiahold limited 1.92 1.92 1.92 1.92 1.81
llp 0 0 0 0 0.29
PARTICULARS Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
FII/DII 39.42 39.13 39.13 39.61 43.08
east bridge capital maste... 4.55 4.55 4.55 4.57 4.32
life insurance corporatio... 7.98 8.28 8.28 8.28 7.83
east bridge capital maste... 2.86 2.86 2.86 2.86 2.71
caisse de depot et placem... 4.19 4.18 4.19 3.42 8.36
caisse de depot et placem... 4.19 4.18 4.19 3.42 8.36
life insurance corporatio... 7.98 8.28 8.28 8.28 7.83
college retirement equiti... 0 0 1.08 1.19 1.15

Company Presentations

Company News

Piramal Enterprises informs about loss of share certificate20 Sep 2021, 4:23PM Piramal Enterprises informs about loss of share certificate15 Sep 2021, 12:01PM Piramal Enterprises informs about issuance of duplicate share certificate13 Sep 2021, 12:00PM Piramal Enterprises informs about issuance of duplicate share certificate 24 Aug 2021, 4:21PM Piramal Enterprises informs about issuance of duplicate share certificates16 Aug 2021, 4:20PM Piramal Enterprises informs about analyst meet10 Aug 2021, 10:03AM Piramal Enterprises reports 9% rise in Q1 consolidated net profit7 Aug 2021, 10:53AM Piramal Enterprises informs about resignation of director27 Jul 2021, 2:10PM Piramal Enterprises informs about chairman’s speech20 Jul 2021, 3:48PM Piramal Enterprises informs about proceedings and voting results of 74th AGM17 Jul 2021, 11:09AM Piramal Enterprises informs about details of loss of certificate16 Jul 2021, 5:18PM Piramal Enterprises informs about disclosure16 Jul 2021, 9:59AM Piramal Enterprises gets nod to raise Rs 102 crore via NCDs13 Jul 2021, 10:15AM Piramal Enterprises gets nod to raise Rs 200 crore through NCDs12 Jul 2021, 10:50AM Piramal Enterprises informs about outcome of committee meeting12 Jul 2021, 10:11AM Piramal Enterprises raises Rs 125.19 crore through NCDs6 Jul 2021, 11:34AM Piramal Enterprises informs about outcome of committee meet5 Jul 2021, 10:47AM Piramal Enterprises gets nod to raise Rs 635 crore on private placement basis5 Jul 2021, 10:37AM Piramal Enterprises raises Rs 365 crore through bonds29 Jun 2021, 10:27AM Piramal Enterprises to raise up to Rs 1,000 crore via NCDs28 Jun 2021, 3:06PM Piramal Enterprises informs about outcome of committee meeting28 Jun 2021, 9:37AM Piramal Enterprises informs about acquisition23 Jun 2021, 10:45AM Piramal Enterprises informs about payment of interest11 Jun 2021, 4:34PM Piramal Enterprises’ arm, NITI Aayog launch home-care support for COVID patients in aspirational districts 9 Jun 2021, 1:08PM Piramal Enterprises informs about analyst meet 19 May 2021, 2:21PM Piramal Enterprises informs about independent auditor's reports14 May 2021, 1:56PM Piramal Enterprises reports consolidated net loss of Rs 571 crore in Q414 May 2021, 10:25AM Piramal Enterprises informs about conference call10 May 2021, 2:27PM Piramal Enterprises’ arm enters into agreement to acquire stake in Hemmo 31 Mar 2021, 3:52PM Piramal Enterprises’ arm raises Rs 4,050 crore through NCDs22 Mar 2021, 11:40AM Piramal Enterprises to cover COVID vaccination costs for employees15 Mar 2021, 4:53PM Piramal Enterprises informs about issuance of duplicate share certificate11 Mar 2021, 3:56PM Piramal Enterprises informs about issuance of duplicate share certificate5 Mar 2021, 4:12PM Piramal Enterprises informs about analyst meet1 Mar 2021, 3:14PM Piramal Enterprises informs about issuance of duplicate share certificate25 Feb 2021, 3:43PM Piramal Enterprises informs about analyst meet24 Feb 2021, 3:41PM Piramal Enterprises submits conference call details8 Feb 2021, 4:10PM Piramal Group’s real estate arm introduces zero percent interest on home loan scheme22 Dec 2020, 11:50AM Piramal Enterprises informs about issuance of duplicate share certificate16 Dec 2020, 3:16PM Piramal Enterprises informs about issuance of duplicate share certificate20 Nov 2020, 11:33AM Piramal Enterprises’ arm approves acquisition of CCPL from Navin Fluorine International29 Oct 2020, 11:11AM Piramal Enterprises informs about issuance of duplicate share certificates7 Oct 2020, 4:38PM Piramal Enterprises’ arm completes 20% stake sale to Carlyle Group7 Oct 2020, 11:43AM Piramal Enterprises informs about schedule of investor meetings18 Sep 2020, 1:06PM Piramal Enterprises informs about investor meet31 Aug 2020, 4:11PM Piramal Group’s real estate arm introduces online booking facility for Thane project 15 Jul 2020, 9:46AM Piramal Enterprises informs about interest payment of NCDs14 Jul 2020, 3:06PM Piramal Enterprises raises Rs 76 crore through bonds8 Jul 2020, 9:12AM Carlyle Group to buy 20% stake in Piramal Enterprises’ arm27 Jun 2020, 1:10PM Piramal Enterprises raises Rs 2590 crore through bonds26 Jun 2020, 9:54AM

Piramal Enterprises Stock Price Analysis and Quick Research Report. Is Piramal Enterprises an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Piramal Enterprises and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 2256.67 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Piramal Enterprises has a Debt to Equity ratio of 0.2878 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Piramal Enterprises , the EPS growth was -72.454493078588 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Piramal Enterprises has OPM of 40.5752032380177 % which is a good sign for profitability.
     
  • ROE: Piramal Enterprises have a poor ROE of 0.174191233160423 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Piramal Enterprises

X